img

Global Antibody Fragments Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antibody Fragments Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antibody Fragments report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antibody Fragments market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Cancer and Immunodeficiencies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antibody Fragments industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antibody Fragments key manufacturers include Novartis, F. Hoffmann-La Roche, Johnson & Johnson, Amgen, Bristol-Myers Squibb, AbbVie, Takeda Pharmaceutical, Sanofi and Biogen, etc. Novartis, F. Hoffmann-La Roche, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Antibody Fragments can be divided into F(ab) Fragment and F(ab’)2 Fragment, etc. F(ab) Fragment is the mainstream product in the market, accounting for % sales share globally in 2022.
Antibody Fragments is widely used in various fields, such as Cancer, Immunodeficiencies and Other,, etc. Cancer provides greatest supports to the Antibody Fragments industry development. In 2022, global % sales of Antibody Fragments went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antibody Fragments market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
F. Hoffmann-La Roche
Johnson & Johnson
Amgen
Bristol-Myers Squibb
AbbVie
Takeda Pharmaceutical
Sanofi
Biogen
Eli Lilly
Segment by Type
F(ab) Fragment
F(ab’)2 Fragment

Segment by Application


Cancer
Immunodeficiencies
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antibody Fragments market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antibody Fragments, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antibody Fragments industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antibody Fragments in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antibody Fragments introduction, etc. Antibody Fragments Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antibody Fragments market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Antibody Fragments Market Overview
1.1 Antibody Fragments Product Overview
1.2 Antibody Fragments Market Segment by Type
1.2.1 F(ab) Fragment
1.2.2 F(ab’)2 Fragment
1.3 Global Antibody Fragments Market Size by Type
1.3.1 Global Antibody Fragments Market Size Overview by Type (2018-2034)
1.3.2 Global Antibody Fragments Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antibody Fragments Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Fragments Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antibody Fragments Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antibody Fragments Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antibody Fragments Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antibody Fragments Sales Breakdown by Type (2018-2024)
2 Global Antibody Fragments Market Competition by Company
2.1 Global Top Players by Antibody Fragments Sales (2018-2024)
2.2 Global Top Players by Antibody Fragments Revenue (2018-2024)
2.3 Global Top Players by Antibody Fragments Price (2018-2024)
2.4 Global Top Manufacturers Antibody Fragments Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody Fragments Market Competitive Situation and Trends
2.5.1 Antibody Fragments Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody Fragments Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Fragments as of 2022)
2.7 Date of Key Manufacturers Enter into Antibody Fragments Market
2.8 Key Manufacturers Antibody Fragments Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibody Fragments Status and Outlook by Region
3.1 Global Antibody Fragments Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antibody Fragments Historic Market Size by Region
3.2.1 Global Antibody Fragments Sales in Volume by Region (2018-2024)
3.2.2 Global Antibody Fragments Sales in Value by Region (2018-2024)
3.2.3 Global Antibody Fragments Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antibody Fragments Forecasted Market Size by Region
3.3.1 Global Antibody Fragments Sales in Volume by Region (2024-2034)
3.3.2 Global Antibody Fragments Sales in Value by Region (2024-2034)
3.3.3 Global Antibody Fragments Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antibody Fragments by Application
4.1 Antibody Fragments Market Segment by Application
4.1.1 Cancer
4.1.2 Immunodeficiencies
4.1.3 Other
4.2 Global Antibody Fragments Market Size by Application
4.2.1 Global Antibody Fragments Market Size Overview by Application (2018-2034)
4.2.2 Global Antibody Fragments Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antibody Fragments Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody Fragments Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antibody Fragments Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antibody Fragments Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antibody Fragments Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antibody Fragments Sales Breakdown by Application (2018-2024)
5 North America Antibody Fragments by Country
5.1 North America Antibody Fragments Historic Market Size by Country
5.1.1 North America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antibody Fragments Sales in Volume by Country (2018-2024)
5.1.3 North America Antibody Fragments Sales in Value by Country (2018-2024)
5.2 North America Antibody Fragments Forecasted Market Size by Country
5.2.1 North America Antibody Fragments Sales in Volume by Country (2024-2034)
5.2.2 North America Antibody Fragments Sales in Value by Country (2024-2034)
6 Europe Antibody Fragments by Country
6.1 Europe Antibody Fragments Historic Market Size by Country
6.1.1 Europe Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antibody Fragments Sales in Volume by Country (2018-2024)
6.1.3 Europe Antibody Fragments Sales in Value by Country (2018-2024)
6.2 Europe Antibody Fragments Forecasted Market Size by Country
6.2.1 Europe Antibody Fragments Sales in Volume by Country (2024-2034)
6.2.2 Europe Antibody Fragments Sales in Value by Country (2024-2034)
7 Asia-Pacific Antibody Fragments by Region
7.1 Asia-Pacific Antibody Fragments Historic Market Size by Region
7.1.1 Asia-Pacific Antibody Fragments Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antibody Fragments Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antibody Fragments Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antibody Fragments Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody Fragments Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antibody Fragments Sales in Value by Region (2024-2034)
8 Latin America Antibody Fragments by Country
8.1 Latin America Antibody Fragments Historic Market Size by Country
8.1.1 Latin America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antibody Fragments Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antibody Fragments Sales in Value by Country (2018-2024)
8.2 Latin America Antibody Fragments Forecasted Market Size by Country
8.2.1 Latin America Antibody Fragments Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antibody Fragments Sales in Value by Country (2024-2034)
9 Middle East and Africa Antibody Fragments by Country
9.1 Middle East and Africa Antibody Fragments Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antibody Fragments Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antibody Fragments Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antibody Fragments Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Fragments Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antibody Fragments Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Antibody Fragments Products Offered
10.1.5 Novartis Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Information
10.2.2 F. Hoffmann-La Roche Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.2.4 F. Hoffmann-La Roche Antibody Fragments Products Offered
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Johnson & Johnson Antibody Fragments Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amgen Antibody Fragments Products Offered
10.4.5 Amgen Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Information
10.5.2 Bristol-Myers Squibb Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers Squibb Antibody Fragments Products Offered
10.5.5 Bristol-Myers Squibb Recent Development
10.6 AbbVie
10.6.1 AbbVie Company Information
10.6.2 AbbVie Introduction and Business Overview
10.6.3 AbbVie Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbbVie Antibody Fragments Products Offered
10.6.5 AbbVie Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Pharmaceutical Antibody Fragments Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Antibody Fragments Products Offered
10.8.5 Sanofi Recent Development
10.9 Biogen
10.9.1 Biogen Company Information
10.9.2 Biogen Introduction and Business Overview
10.9.3 Biogen Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biogen Antibody Fragments Products Offered
10.9.5 Biogen Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Antibody Fragments Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Eli Lilly Antibody Fragments Products Offered
10.10.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Fragments Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Fragments Industrial Chain Analysis
11.4 Antibody Fragments Market Dynamics
11.4.1 Antibody Fragments Industry Trends
11.4.2 Antibody Fragments Market Drivers
11.4.3 Antibody Fragments Market Challenges
11.4.4 Antibody Fragments Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Fragments Distributors
12.3 Antibody Fragments Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of F(ab) Fragment
Table 2. Major Company of F(ab’)2 Fragment
Table 3. Global Antibody Fragments Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Antibody Fragments Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Antibody Fragments Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Antibody Fragments Sales by Type (2018-2024) & (US& Million)
Table 7. Global Antibody Fragments Market Share in Value by Type (2018-2024)
Table 8. Global Antibody Fragments Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Antibody Fragments Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Antibody Fragments Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Antibody Fragments Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Antibody Fragments Sales Market Share in Value by Type (2024-2034)
Table 13. Global Antibody Fragments Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Antibody Fragments Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Antibody Fragments Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Antibody Fragments Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Antibody Fragments Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Antibody Fragments Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Antibody Fragments Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Antibody Fragments Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Antibody Fragments Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Antibody Fragments Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Antibody Fragments Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Antibody Fragments Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Antibody Fragments Sales Share by Company (2018-2024)
Table 26. Global Antibody Fragments Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Antibody Fragments Revenue Share by Company (2018-2024)
Table 28. Global Market Antibody Fragments Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Antibody Fragments Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Antibody Fragments Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Fragments as of 2022)
Table 32. Date of Key Manufacturers Enter into Antibody Fragments Market
Table 33. Key Manufacturers Antibody Fragments Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antibody Fragments Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Antibody Fragments Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Antibody Fragments Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Antibody Fragments Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Antibody Fragments Sales Market Share in Value by Region (2018-2024)
Table 40. Global Antibody Fragments Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Antibody Fragments Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Antibody Fragments Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Antibody Fragments Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Antibody Fragments Sales Market Share in Value by Region (2024-2034)
Table 45. Global Antibody Fragments Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Antibody Fragments Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Antibody Fragments Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Antibody Fragments Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Antibody Fragments Sales Market Share in Value by Application (2018-2024)
Table 51. Global Antibody Fragments Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Antibody Fragments Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Antibody Fragments Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Antibody Fragments Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Antibody Fragments Sales Market Share in Value by Application (2024-2034)
Table 56. Global Antibody Fragments Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Antibody Fragments Sales by Application (2018-2024) (K Pcs)
Table 58. North America Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Antibody Fragments Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Antibody Fragments Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Antibody Fragments Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Antibody Fragments Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Antibody Fragments Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Antibody Fragments Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Antibody Fragments Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Antibody Fragments Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Antibody Fragments Sales Market Share in Value by Country (2018-2024)
Table 71. North America Antibody Fragments Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Antibody Fragments Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Antibody Fragments Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Antibody Fragments Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Antibody Fragments Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Antibody Fragments Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Antibody Fragments Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Antibody Fragments Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Antibody Fragments Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Antibody Fragments Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Antibody Fragments Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Antibody Fragments Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Antibody Fragments Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Antibody Fragments Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Antibody Fragments Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Antibody Fragments Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Antibody Fragments Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Antibody Fragments Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Antibody Fragments Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Antibody Fragments Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Antibody Fragments Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Antibody Fragments Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Antibody Fragments Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Antibody Fragments Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Antibody Fragments Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Antibody Fragments Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Antibody Fragments Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Antibody Fragments Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Antibody Fragments Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Antibody Fragments Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Antibody Fragments Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Antibody Fragments Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Antibody Fragments Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Antibody Fragments Sales Market Share in Value by Country (2024-2034)
Table 107. Novartis Company Information
Table 108. Novartis Introduction and Business Overview
Table 109. Novartis Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Novartis Antibody Fragments Product
Table 111. Novartis Recent Development
Table 112. F. Hoffmann-La Roche Company Information
Table 113. F. Hoffmann-La Roche Introduction and Business Overview
Table 114. F. Hoffmann-La Roche Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. F. Hoffmann-La Roche Antibody Fragments Product
Table 116. F. Hoffmann-La Roche Recent Development
Table 117. Johnson & Johnson Company Information
Table 118. Johnson & Johnson Introduction and Business Overview
Table 119. Johnson & Johnson Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Johnson & Johnson Antibody Fragments Product
Table 121. Johnson & Johnson Recent Development
Table 122. Amgen Company Information
Table 123. Amgen Introduction and Business Overview
Table 124. Amgen Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Amgen Antibody Fragments Product
Table 126. Amgen Recent Development
Table 127. Bristol-Myers Squibb Company Information
Table 128. Bristol-Myers Squibb Introduction and Business Overview
Table 129. Bristol-Myers Squibb Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Bristol-Myers Squibb Antibody Fragments Product
Table 131. Bristol-Myers Squibb Recent Development
Table 132. AbbVie Company Information
Table 133. AbbVie Introduction and Business Overview
Table 134. AbbVie Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. AbbVie Antibody Fragments Product
Table 136. AbbVie Recent Development
Table 137. Takeda Pharmaceutical Company Information
Table 138. Takeda Pharmaceutical Introduction and Business Overview
Table 139. Takeda Pharmaceutical Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Takeda Pharmaceutical Antibody Fragments Product
Table 141. Takeda Pharmaceutical Recent Development
Table 142. Sanofi Company Information
Table 143. Sanofi Introduction and Business Overview
Table 144. Sanofi Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Sanofi Antibody Fragments Product
Table 146. Sanofi Recent Development
Table 147. Biogen Company Information
Table 148. Biogen Introduction and Business Overview
Table 149. Biogen Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Biogen Antibody Fragments Product
Table 151. Biogen Recent Development
Table 152. Eli Lilly Company Information
Table 153. Eli Lilly Introduction and Business Overview
Table 154. Eli Lilly Antibody Fragments Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Eli Lilly Antibody Fragments Product
Table 156. Eli Lilly Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Antibody Fragments Market Trends
Table 160. Antibody Fragments Market Drivers
Table 161. Antibody Fragments Market Challenges
Table 162. Antibody Fragments Market Restraints
Table 163. Antibody Fragments Distributors List
Table 164. Antibody Fragments Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Fragments Product Picture
Figure 2. Global Antibody Fragments Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antibody Fragments Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antibody Fragments Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of F(ab) Fragment
Figure 6. Global F(ab) Fragment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of F(ab’)2 Fragment
Figure 8. Global F(ab’)2 Fragment Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Antibody Fragments Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Antibody Fragments Sales Market Share by Type in 2022 & 2034
Figure 11. North America Antibody Fragments Sales Market Share in Volume by Type in 2022
Figure 12. North America Antibody Fragments Sales Market Share in Value by Type in 2022
Figure 13. Europe Antibody Fragments Sales Market Share in Volume by Type in 2022
Figure 14. Europe Antibody Fragments Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Antibody Fragments Sales Market Share in Value by Type in 2022
Figure 17. Latin America Antibody Fragments Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Antibody Fragments Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Antibody Fragments Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Antibody Fragments Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Fragments Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Fragments Revenue in 2022
Figure 23. Antibody Fragments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Cancer
Figure 25. Global Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Immunodeficiencies
Figure 27. Global Immunodeficiencies Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Antibody Fragments Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Antibody Fragments Sales Market Share by Application in 2022 & 2034
Figure 32. North America Antibody Fragments Sales Market Share in Volume by Application in 2022
Figure 33. North America Antibody Fragments Sales Market Share in Value by Application in 2022
Figure 34. Europe Antibody Fragments Sales Market Share in Volume by Application in 2022
Figure 35. Europe Antibody Fragments Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Antibody Fragments Sales Market Share in Value by Application in 2022
Figure 38. Latin America Antibody Fragments Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Antibody Fragments Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Antibody Fragments Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Antibody Fragments Manufacturing Cost Structure
Figure 43. Antibody Fragments Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed